BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 28188790)

  • 1. The role of ELK3 to regulate peritumoral lymphangiogenesis and VEGF-C production in triple negative breast cancer cells.
    Oh N; Park JI; Park JH; Kim KS; Lee DR; Park KS
    Biochem Biophys Res Commun; 2017 Mar; 484(4):896-902. PubMed ID: 28188790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer.
    Zhu G; Huang Q; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Wang J; Ye J
    Oncotarget; 2016 Nov; 7(45):73711-73724. PubMed ID: 27713159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ELK3-GATA3 axis orchestrates invasion and metastasis of breast cancer cells in vitro and in vivo.
    Kong SY; Kim KS; Kim J; Kim MK; Lee KH; Lee JY; Oh N; Park JI; Park JH; Heo SH; Shim SH; Lee DR; Kim KP; Park KS
    Oncotarget; 2016 Oct; 7(40):65137-65146. PubMed ID: 27556500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
    Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S
    Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.
    Kim KS; Park JI; Oh N; Cho HJ; Park JH; Park KS
    Sci Rep; 2019 Jun; 9(1):8418. PubMed ID: 31182803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagy.
    Park JH; Kim KP; Ko JJ; Park KS
    Biochem Biophys Res Commun; 2016 Aug; 477(2):277-82. PubMed ID: 27301639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W; Jia L; Song N; Lu XA; Ding Y; Wang X; Song X; Fu Y; Luo Y
    Clin Cancer Res; 2012 Oct; 18(19):5387-98. PubMed ID: 22932666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.
    Kim KS; Kim J; Oh N; Kim MY; Park KS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):509-515. PubMed ID: 29510139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CCL21/CCR7 chemokine axis in breast cancer-induced lymphangiogenesis.
    Tutunea-Fatan E; Majumder M; Xin X; Lala PK
    Mol Cancer; 2015 Feb; 14():35. PubMed ID: 25744065
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-mobility group box 1 protein activating nuclear factor-κB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
    Li Y; He J; Zhong D; Li J; Liang H
    J Int Med Res; 2015 Aug; 43(4):494-505. PubMed ID: 26001393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.
    Liu D; Li L; Zhang XX; Wan DY; Xi BX; Hu Z; Ding WC; Zhu D; Wang XL; Wang W; Feng ZH; Wang H; Ma D; Gao QL
    Cancer Res; 2014 Oct; 74(19):5597-607. PubMed ID: 25142796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
    Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
    Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
    Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
    Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin α6 overexpression promotes lymphangiogenesis and lymphatic metastasis via activating the NF-κB signaling pathway in lung adenocarcinoma.
    Ren S; Wang J; Xu A; Bao J; Cho WC; Zhu J; Shen J
    Cell Oncol (Dordr); 2022 Feb; 45(1):57-67. PubMed ID: 35025009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
    Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
    J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steroid receptor coactivator-1 interacts with NF-κB to increase VEGFC levels in human thyroid cancer.
    Gao B; Guo L; Luo D; Jiang Y; Zhao J; Mao C; Xu Y
    Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29717026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OxLDL promotes lymphangiogenesis and lymphatic metastasis in gastric cancer by upregulating VEGF‑C expression and secretion.
    Ma C; Xie J; Luo C; Yin H; Li R; Wang X; Xiong W; Zhang T; Jiang P; Qi W; Zhou T; Yang Z; Wang W; Ma J; Gao G; Yang X
    Int J Oncol; 2019 Feb; 54(2):572-584. PubMed ID: 30483757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.